The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients-Reference-Cited by-同舟云学术

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Published:2020-05-21 Issue:21 Volume:135 Page:1912-1915
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Treon Steven P.¹²^ORCID,Castillo Jorge J.¹²^ORCID,Skarbnik Alan P.³,Soumerai Jacob D.²⁴,Ghobrial Irene M.¹²,Guerrera Maria Luisa¹²,Meid Kirsten¹,Yang Guang¹²^ORCID

Affiliation:

1. Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA;

2. Department of Medicine, Harvard Medical School, Boston, MA;

3. Lymphoproliferative Disorders Program, Novant Health, Charlotte, NC; and

4. Massachusetts General Hospital, Boston, MA

Abstract

Treon et al provide early clinical data supporting a theoretical rationale for continuing ibrutinib in patients receiving the drug during COVID-19 illness.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/135/21/1912/1800674/bloodbld2020006288.pdf

Reference25 articles.

1. Inhibiting Bruton’s tyrosine kinase rescues mice from lethal influenza-induced acute lung injury;Florence;Am J Physiol Lung Cell Mol Physiol,2018

2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020

3. Covid-19 in critically ill patients in the Seattle region - case series [published online ahead of print 30 March 2020];Bhatraju;N Engl J Med

4. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [published online ahead of print 30 March 2020];Cao;N Engl J Med

5. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published online ahead of print 13 March 2020];Wu;JAMA Intern Med

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton's tyrosine kinase inhibition for the treatment of allergic disorders;Annals of Allergy, Asthma & Immunology;2024-07

2. The impact of Bruton’s tyrosine kinase inhibitor treatment on COVID-19 outcomes in Chinese patients with chronic lymphocytic leukemia;Frontiers in Oncology;2024-05-21

3. Clinical Features and Prognostic Predictors in Patients with Renal Transplant Complicated by SARS-CoV-2 Infection, a Retrospective Single-Center Study;Infection and Drug Resistance;2024-05

4. The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic;Ageing Research Reviews;2024-02

5. Inhibition of Polyinosinic-Polycytidylic Acid-Induced Acute Pulmonary Inflammation and NF-κB Activation in Mice by a Banana Plant Extract;International Journal of Medical Sciences;2024